Synchronous double primary vulvar melanoma: a not so rare possibility. A clinical and dermoscopic case study

Melanoma and Skin Cancer

Impact of particulate matter exposure on melanoma risk: A multicentre case-control study

J Eur Acad Dermatol Venereol

Bellinato F, Adami G, Reatini MA, Cattani G, Cannizzaro MV, Del Regno L, Peris K, Gisondi P, Girolomoni G

doi: 10.1111/jdv.20539

Melanoma and Skin Cancer

High dose vitamin D supplementation does not improve outcome in a cutaneous melanoma population: results of a randomized double-blind, placebo-controlled study (ViDMe trial)

Br J Dermatol

De Smedt J, Van Kelst S, Janssen L, Marasigan V, Boecxstaens V, Bogaerts K, Belmans A, Vanderschueren D, Vandenberghe K, Bechter O, Aura C, Lambrechts D, Strobbe T, Emri G, Nikkels A, Garmyn M

doi: 10.1093/bjd/ljae257

Psoriasis

Efficacy and safety of the ustekinumab biosimilar ABP 654 in patients with moderate-to-severe plaque psoriasis: a randomized, double-blinded, active-controlled, comparative clinical study over 52 weeks

Br J Dermatol

Blauvelt A, Papp K, Trivedi M, Barragan C, Chow V, Mytych DT, Yamauchi P, Crowley J, Franklin J

doi: 10.1093/bjd/ljae402

Osteoarthritis

Association of intra-articular injection and knee arthroscopy prior to primary knee replacement with the timing and outcomes of surgery: Retrospective cohort study using data from the Clinical Practice Research Datalink GOLD database

PLoS One

Strang M, Broomfield J, Whitehouse M, Kunutsor S, Glyn-Jones S, Delmestri A, Blom A, Judge A

doi: 10.1371/journal.pone.0311947

Psoriasis

A Randomized, Double-blind, Phase III Study Assessing Clinical Similarity of SB17 (Proposed Ustekinumab Biosimilar) to Reference Ustekinumab in Subjects with Moderate to Severe Plaque Psoriasis

J Am Acad Dermatol

Feldman SR, Narbutt J, Girolomoni G, Brzezicki J, Reznichenko N, Zegadlo-Mylik MA, Pulka G, Dmowska-Stecewicz M, Kłujszo E, Rekalov D, Rajzer L, Lee J, Lee M, Rho YH

doi: 10.1016/j.jaad.2024.04.045

Immunodeficiency

Long-Term Safety of Facilitated Subcutaneous Immunoglobulin 10% Treatment in US Clinical Practice in Patients with Primary Immunodeficiency Diseases: Results from a Post-Authorization Safety Study

J Clin Immunol

Rubinstein A, Mabudian M, McNeil D, Patel NC, Wasserman RL, Gupta S, Carrasco P, Chen J, Garcia E, Nagy A, Yel L

doi: 10.1007/s10875-024-01769-8

Alopecia Areata

Epidemiological, clinical and economic burden of alopecia areata in Spain: a real-world retrospective study. The PETALO study

Eur J Dermatol

Vañó-Galván S, Figueras-Nart I, Artime E, Díaz-Cerezo S, Núñez M, Iglesias C, Artés M, Huete T

doi: 10.1684/ejd.2024.4654

Melanoma and Skin Cancer

Relation between dabrafenib plus trametinib-induced pyrexia and age in BRAF V600-mutated metastatic melanoma patients: A post hoc analysis of the real-world ELDERLYMEL study

Melanoma Res

González-Barrallo I, Castellón Rubio VE, Medina J, España Fernández S, Mujika K, Majem M, Aguado C, Cabrera Suárez MÁ, Palacio I, Osterloh L, Martínez-Fernández A, García-Castaño A

doi: 10.1097/CMR.0000000000001020

Melanoma and Skin Cancer

Tumor Upstaging in Invasive Melanoma is Associated with Changes in Clinical Management and Worse Prognosis

J Am Acad Dermatol

Rosenthal A, Kim JY, Juhasz ML, Conde G, Chen C, Eng S, Carrasco Mendoza CA, Chang CT, Ticknor I, Doan L, Schwarzmann KB, Garzione S, Li Y, Islas ZA, Gharavi NM, Man JR

doi: 10.1016/j.jaad.2024.11.028

Related content

Impact of particulate matter exposure on melanoma risk: A multicentre case-control study

High dose vitamin D supplementation does not improve outcome in a cutaneous melanoma population: results of a randomized double-blind, placebo-controlled study (ViDMe trial)

Efficacy and safety of the ustekinumab biosimilar ABP 654 in patients with moderate-to-severe plaque psoriasis: a randomized, double-blinded, active-controlled, comparative clinical study over 52 weeks

Association of intra-articular injection and knee arthroscopy prior to primary knee replacement with the timing and outcomes of surgery: Retrospective cohort study using data from the Clinical Practice Research Datalink GOLD database

A Randomized, Double-blind, Phase III Study Assessing Clinical Similarity of SB17 (Proposed Ustekinumab Biosimilar) to Reference Ustekinumab in Subjects with Moderate to Severe Plaque Psoriasis

Long-Term Safety of Facilitated Subcutaneous Immunoglobulin 10% Treatment in US Clinical Practice in Patients with Primary Immunodeficiency Diseases: Results from a Post-Authorization Safety Study

Epidemiological, clinical and economic burden of alopecia areata in Spain: a real-world retrospective study. The PETALO study

Relation between dabrafenib plus trametinib-induced pyrexia and age in BRAF V600-mutated metastatic melanoma patients: A post hoc analysis of the real-world ELDERLYMEL study

Tumor Upstaging in Invasive Melanoma is Associated with Changes in Clinical Management and Worse Prognosis